Schizophrenia News and Research

Latest Schizophrenia News and Research

Study: Stem cell transplant heals neurological deficits in mice

For the first time, human embryonic stem cells have been transformed into nerve cells that helped mice regain the ability to learn and remember.

22 Apr 2013

Targacept moving forward with Phase 2b study of TC-5619 for treatment of schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced that it has completed recruitment of patients in the Phase 2b study of TC-5619 as a treatment for negative symptoms and cognitive dysfunction in schizophrenia.

19 Apr 2013

Excess glutamate drives schizophrenia in high-risk individuals

An excess of the brain neurotransmitter glutamate may cause a transition to psychosis in people who are at risk for schizophrenia, reports a study from investigators at Columbia University Medical Center published in the current issue of Neuron.

19 Apr 2013

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

The Korea-based international pharmaceutical company, SK Biopharmaceuticals, announced today the U.S. Food and Drug Administration has authorized the Investigational New Drug application for SKL15508 to treat cognitive impairment associated with schizophrenia.

18 Apr 2013

New research reveals how acute stress primes brain for improved performance

Overworked and stressed out? Look on the bright side. Some stress is good for you. "You always think about stress as a really bad thing, but it's not," said Daniela Kaufer, associate professor of integrative biology at the University of California, Berkeley.

17 Apr 2013

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

BioLineRx, a biopharmaceutical development company, announced today positive Phase IIa results for BL-7040, an orally available drug for treating inflammatory bowel disease.

17 Apr 2013

Electroconvulsive therapy improves quality of life in patients with severe depression

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.

16 Apr 2013

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its Phase IIa clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

16 Apr 2013

Johns Hopkins researchers to highlight progress in genetic research at international meeting

Johns Hopkins genetics researchers Aravinda Chakravarti, Ph.D., and David Valle, M.D., will each present at the joint conference of the Human Genome Meeting 2013 and the 21st International Congress of Genetics.

15 Apr 2013

Nearly 8% of patients in VHA visit emergency department two or more times per year: Study

Even with health insurance, ready access to preventive, specialty and behavioral health care and comprehensive electronic medical records, nearly 8 percent of patients in the Veterans Health Administration visit the emergency department two or more times per year, according to a study published online Tuesday in Annals of Emergency Medicine ("What Drives Frequent Emergency Department Use in an Integrated Health System: National Data from the Veterans Health Administration").

15 Apr 2013

Stigma of mental illness, a public health concern

An international study found that despite widespread acceptance that mental illness is a disease that can be effectively treated, a common "backbone" of prejudice exists that unfairly paints people with conditions such as depression and schizophrenia as undesirable for close personal relationships and positions of authority.

12 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.

11 Apr 2013

Study finds Google searches for information about mental illnesses, problems follow seasonal patterns

A new study published in the May issue of the American Journal of Preventive Medicine finds that Google searches for information across all major mental illnesses and problems followed seasonal patterns, suggesting mental illness may be more strongly linked with seasonal patterns than previously thought.

10 Apr 2013

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces top-line results from REFRESH, a phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

10 Apr 2013

Multiple genes strongly contribute to risk for schizophrenia

Multiple genes contribute to risk for schizophrenia and appear to function in pathways related to transmission of signals in the brain and immunity, according to an international study led by Virginia Commonwealth University School of Pharmacy researchers.

10 Apr 2013

Research sheds light on malaria-related parasite's transition from acute to chronic stage

A new discovery about the malaria-related parasite Toxoplasma gondii -- which can threaten babies, AIDS patients, the elderly and others with weakened immune function -- may help solve the mystery of how this single-celled parasite establishes life-long infections in people.

10 Apr 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Study: Stem cell transplant heals neurological deficits in mice

Targacept moving forward with Phase 2b study of TC-5619 for treatment of schizophrenia

Excess glutamate drives schizophrenia in high-risk individuals

FDA authorizes SK Biopharmaceuticals' IND application for SKL15508 to treat CIAS

New research reveals how acute stress primes brain for improved performance

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

Electroconvulsive therapy improves quality of life in patients with severe depression

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

Johns Hopkins researchers to highlight progress in genetic research at international meeting

Nearly 8% of patients in VHA visit emergency department two or more times per year: Study

Stigma of mental illness, a public health concern

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

Study finds Google searches for information about mental illnesses, problems follow seasonal patterns

REFRESH study: RP5063 shows promise for schizophrenia and schizoaffective disorder

Multiple genes strongly contribute to risk for schizophrenia

Research sheds light on malaria-related parasite's transition from acute to chronic stage

Roche, Isis Pharmaceuticals to develop neurodegenerative therapeutics for Huntington's disease

Schizophrenia patients experiencing relapse are more likely to develop UTIs

Article describes Brain Activity Mapping could bring new understanding of how brain works

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in